





Human Skeletal Muscle Satellite Cells Co-Express 
Aldehyde Dehydrogenase Isoforms Aldh1A1 & Aldh1A3 
Abstract
Satellite cells (SC) constitute the stem cell population of skeletal muscle and conduct myogenic growth and differentiation. Recently, aldehyde dehydrogenase 
1 (ALDH1) has been identified as a novel myogenic factor in experimental models of SCs. ALDH1 constitutes a subfamily of the ALDH enzyme super family. 
The enzymatic functions of ALDH1 isoforms include both protection against oxidative stress products and regulation of differentiation as pacemaker enzyme in 
retinoic acid signaling. Although ALDH enzymatic activity has been demonstrated in SCs it is not clear which isoforms are important in human skeletal muscle. 
Here, we show that ALDH1A1 and ALDH1A3 are expressed in human SCs. Using antibodies directed against ALDH1 and its isoforms ALDH1A1 and ALDH1A3, 
respectively, we demonstrate immunohistochemical staining in peri-fascicular position matching the localization of SCs. Consistently, co-immunofluorescence 
reveals ALDH1 expression in CD56 positive stem cells and co-localization of the isoforms ALDH1A1 and ALDH1A3 in Pax7 positive SCs. Quantitative analysis of 
immunohistochemical staining showed no significant differences in the distribution of ALDH1 positive SCs in the skeletal muscle groups pectoralis, diaphragm and 
psoas that have been investigated in the present study. In conclusion, human SCs co-express the ALDH1 isoforms ALDH1A1 and ALDH1A3.
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Introduction
Satellite Cells (SC) constitute the stem cell population of skeletal muscle. 
The biological regulation of functional stem cell behavior, however, is not 
completely understood. Furthermore, exogenous and endogenous stimuli 
that control asymmetric division of SC have not been characterized in detail.
Aldehyde dehydrogenase (ALDH) has recently been identified as a novel 
myogenic factor in SC. It has been shown that ALDH1 expression correlates 
with growth and regenerative capacity in human and murine myogenic 
progenitor cells [1]. These results have been corroborated by experiments 
demonstrating high myogenic capacities and resistance to oxidative and 
inflammatory stress in ALDH1 expressing cells [2]. Most recently, Etienne et 
al. investigated various ALDH isoforms in different species and also included 
dystrophic muscle tissue from human and dog model system of DMD. They 
pointed out the important role of ALDH isoforms in muscle physiology and 
homeostasis, especially in the context of muscular dystrophies [3].
ALDH constitutes an enzyme super family with various isoforms and different 
functions in cell metabolism. ALDH2 is the most important enzyme in alcohol 
metabolism of the liver by detoxifying acetate aldehyde [4]. Other isoforms 
of ALDH are known as detoxifying agents in oxidative stress reaction after 
lipid peroxidation [5]. Thus, ALDH enzymes act as important factors in 
cellular protection. In addition, isoforms of the ALDH1 subfamily, especially 
ALDH1A1 and ALDH1A3, are most important regulators of retinoic acid (RA) 
metabolism, thereby activating differentiation [6,7].   
These data indicate that ALDH1 seems to play an important role in skeletal 
muscle biology. The cellular function of ALDH1 might include both protection 
against oxidative stress and coordination of differentiation by regulation of 
RA signaling. Therefore, it is of particular interest to learn more about the 
functional expression of ALDH1 in SCs.
Here, we show that ALDH1 is expressed in CD56 positive stem cells of human 
skeletal muscle and that its isoforms ALDH1A1 and ALDH1A3 co-localize 
with Pax7 positive SCs. Quantitative analysis of immunohistochemical 
stainings in different human muscles showed no significant differences in 
the distribution of ALDH1 positive Scs.
Material and Methods 
21 skeletal muscle samples of 7 autopsy cases (3 male, 4 female, mean 
age 58,4 years, range 25-87) selected from the archives of TUM Institute 
of Pathology, were used. The study comply with the guidelines for human 
studies and the research was conducted in accordance with the World 
Medical Association Declaration of Helsinki. Patients’ data have been 
completely anonymized before histological procedure.Tissue specimens 
from pectoralis, diaphragm and psoas muscles, respectively, were prepared 
during regular autopsy, formalin fixed and paraffin embedded. 
Anti-CD56 (Cell Marque; monoclonal, MRQ-42, rabbit, dilution: 1:4, ready 
to use antibody), anti-Pax7 (Merck; polyclonal, rabbit, dilution: 1:500), anti-
ALDH1 (BD Biosciences; monoclonal, clone 44, mouse, dilution: 1:250), 
anti-ALDH1A1 (Abcam; polyclonal, rabbit, dilution: 1:500), anti-ALDH1A3 
(Thermo Fisher Scientific; polyclonal, rabbit, dilution: 1:250) and anti-CD68 
(Dako; monoclonal, KP1, mouse, 1:15000) were used as primary antibodies 
for immunohistochemistry (IHC) and immunofluorescence (IF). Anti-mouse 
(Abcam; goat anti-mouse IgG; 1:400) and anti-rabbit (Abcam; goat anti-
rabbit IgG, 1:400) served as secondary antibodies for IHC. Fluorescent anti-
mouse (Invitrogen; Alexa Fluor 488, 1:2000; Life Technologies; Alexa Fluor 
568, 1:2000, respectively) and fluorescent anti-rabbit (Life technologies; 
Alexa Fluor 488, 1:2000; Invitrogen; Alexa Fluor 568, 1:2000, respectively) 
served as secondary antibodies for IF.
Briefly, for IHC slides were boiled for heat-induced epitope uncovering in 
pH6.0 citrate buffer at 95°C for 30 minutes. After H2O2-incubation, primary 
antibodies were applied as indicated above. Slides were incubated overnight 
at 4°C with subsequent visualization using ABC-reagent (Vector laboratories) 
and 3,3′-diaminobenzidine-(DAB)-reagent (Agilent). Counterstaining with 
hematoxylin was conducted as last step. Positive controls served as quality 
assurance.
Immunohistochemical slides were examined with a light microscope Axioskop 
2 (Zeiss), captured with an AxioCam and analyzed using AxioVision 4.8 
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software. For quantitative evaluation an area of 50 representative cross-
orientated fibers per sample was randomly chosen and positive nucleic 
staining (Pax7) as well as cytoplasmatic staining (CD56, ALDH1) was 
counted.  All 21 samples (7 autopsy cases with 3 different muscle types 
each) were evaluated in the expression-pattern of myogenic stem cell 
markers CD56, Pax7 and enzyme ALDH1 within isoforms ALDH1A1 and 
ALDH1A3. 
For immunofluorescence (IF) staining secondary antibodies of CD56 and 
Pax7 were visualized with fluorescein isothiocynate (FITC) filter, secondary 
antibodies of ALDH1, ALDH1A1 and ALDH1A3 with rhodamine filter.
Briefly, slides were boiled in pH 6.0 citrate buffer at 95°C for 30 minutes 
for epitope uncovering. Primary antibodies were applied as indicated with 
overnight incubation at 4°C. Subsequently, fluorescent secondary antibodies 
were applied and incubated for 45 minutes. Slides were additionally treated 
with Quenching Kit (Vector) for 4 minutes and DAPI counterstaining. Positive 
controls served as quality assurance.
Immunofluorescent slides were examined with a Carl Zeiss Axioplan 
fluorescence microscope. Co-expression of CD56/ ALDH1, PAX7/ ALDH1A1 
and Pax7/ ALDH1A3, respectively, was analyzed by co-immunofluorescence 
staining using different secondary antibodies for visualization. 
Results
ALDH1 immunoreactive cells as well as cells positive for ALDH1A1 and 
ALDH1A3 isoforms were detected in all types of skeletal muscle tissue 
investigated in the present study, showing a peri-fascicular localization along 
the host muscle fiber, but above the sarcolemma. In general, staining pattern 
of ALDH1 did not show significant differences compared to its isoforms 
ALDH1A1 and ALDH1A3 (shown in Fig. 1. E-G) Especially in longitudinal 
orientation of single fibers cytoplasmic ALDH1 staining could be observed 
(shown in Fig. 1. E) although a faint staining of muscle fiber membranes was 
also visible on cross sections. SCs could be identified beneath the basal 
lamina in human skeletal muscle tissue using antibodies directed against 
CD56 and paired-box protein PAX7 (shown in Fig. 1. B-D). Additionally, 
SCs were often situated in a triangle position between fibers (shown in Fig. 
1. A). In comparison, CD56-/ Pax7-positive SCs demonstrated the same 
distribution compared to ALDH1 and cells reactive to its isoforms ALDH1A1 
and ALDH1A3, respectively (shown in Fig. 1.). 
ALDH1 distribution pattern was nearly balanced in the muscle groups 
investigated in the present study (pectoralis, diaphragm, psoas; shown in 
Tab. 1. B). Quantitative analysis using the pan-ALDH1 antibody including all 
ALDH1 isoforms showed a mean value of 31.5 ALDH1 positive cells per 50 
fibers, and there was a trend of more ALDH1A3 immunoreactive cells (mean 
value 10.2) than ALDH1A1 (mean value 7.6). The majority of ALDH1A1 
(mean value 12) and ALDH1A3 positive cells (mean value 12.5) could be 
found in pectoralis muscle (shown in Tab. 1. B).
Analysis of SCs in skeletal muscle using CD56 and Pax7 antibodies showed 
a mean value of 19.4 CD56 and 10.8 Pax7 positive cells per 50 fibers. In 
detail, the majority of CD56 immunoreactive cells could be found in pectoralis 
muscle and diaphragm (mean 22.5 and 22, respectively) compared to psoas 
muscle (mean value 13.8; shown in Tab. 1. A). In contrast, a balanced 
distribution of Pax7 immunoreactive SC was observed in all muscle groups 
(shown in Tab. 1. A).
Co-immunofluorescent staining illustrated the majority of CD56 positive SCs 
with a co-expression of cytoplasmatic ALDH1 (shown in Fig. 2. A, B). The 
majority of Pax7 positive SCs co-expressed the isoforms ALDH1A1 and 
ALDH1A3, respectively (shown in Fig. 2 C, D). Non-SCs expressing ALDH1 
were most likely to be immunohistochemically CD68 positive macrophages. 
Discussion
Satellite cells (SCs) are the stem cells of skeletal muscle and therefore an 
important cell population for muscle growth and myotube formation. SCs 
are not only physiologically regulated through growth and differentiation 
signals, but also activated for regenerative responses by adverse stimuli, 
including inflammation or insults [2]. Interestingly, the enzyme aldehyde 
dehydrogenase 1 (ALDH1) plays a functional role both in differentiation 
by regulation of retinoic acid (RA) metabolism [7] and in detoxification of 
oxidative stress products [5]. ALDH enzymatic activity has been attributed 
to SCs in experimental studies [2,3]. Thus, the enzyme ALDH1 could be 
a potential mediator between physiological mechanisms and regenerative 
processes of SC regulation.  
In the present study, we investigated human skeletal muscle tissues for 
the expression of ALDH1 and its isoforms ALDH1A1 and ALDH1A3. By 
immunohistochemistry we were able to demonstrate ALDH1 expression in 
all included muscle groups. More importantly, ALDH1 positive cells were 
found in the peri-fascicular stem cell niche and morphologically resembled 
SCs. They co-localized with CD56 and Pax7 expressing SCs, and CD56 
and PAX7 immunoreactive cells showed ALDH1 expression by co-
immunofluorescence. Evaluation of ALDH1A1 and ALDH1A3 isoforms did 
not show significant differences in the staining pattern compared to pan-
ALDH1. 
We used human skeletal muscle tissue from autopsies without clinical 
history of muscle disease or pathological finding in muscle tissue during 
autopsy. Therefore, tissue samples represented normal skeletal muscle and 
allowed an insight into ALDH1 histology in human SCs under physiological 
conditions. Our results clearly indicate that ALDH1 and its isoforms ALDH1A1 
and ALDH1A3 are expressed by SCs in human skeletal muscle tissue.
Our data confirmed previous results from experimental findings [1,8]. In 
these experiments, myoblasts were isolated by their ALDH enzymatic activity 
using the Aldefluor assay and sorted by fluorescence-activated cell sorting 
(FACS). [1] (2009) showed that sorted human ALDH positive progenitor 
cells contained after cultivation a CD56- and ALDH-positive subpopulation 
with high myogenic differentiation potential both in vitro and in a xenograft 
transplantation model. In their study they used an anti-ALDH1 antibody. 
Based on the enzymatic activity and the immunofluorescence signal they 
claimed that this antibody was specific for the ALDH1A1 isoform. In our 
experiments, we used three different antibodies that were not available at the 
time of their study and could show the presence of ALDH1 and its isoforms 
by the use of a pan-ALDH1 antibody as well as antibodies against ALDH1A1 
and ALDH1A3, respectively.
[8] (2011) used ALDH positive progenitors from a broad range of species 
including human muscle tissue. They confirmed the prior results and showed 
a high myogenic potential of ALDH expressing cells. Moreover, they were 
able to demonstrate that ALDH positive cells were more resistant against 
oxidative (H2O2) and inflammatory (TNF-α) stress, respectively, indicating 
a role in detoxification of SCs. By lentiviral knock-down they identified the 
ALDH1A1 as the isoform responsible for enzymatic activity. 
More recently, [3] (2020) investigated human ALDH positive skeletal 
muscle cells after Aldefluor fluorescent activated cell sorting (FACS) for 
the expression of ALDH isoforms and identified different isoforms including 
ALDH1A1 and ALDH1A3 that have been also demonstrated in our results. 
Moreover, they showed changes in the expression pattern between control 
individuals and patients suffering from Duchenne’s Muscle Dystrophy (DMD). 
However, these patterns were not identical in human DMD skeletal muscles 
compared with muscle tissue from a dog DMD model. 
Quantitative analysis of the immunohistochemical staining results revealed 
higher numbers of CD56 positive SCs in pectoralis muscle and diaphragm 
compared to psoas muscle but a more homogenous distribution of Pax7 
positive SCs in all muscle groups of our study. The number of CD56 positive 
cells was higher than Pax7 positivity. CD56 is an established marker for SCs in 
all developmental stages, whereas Pax7 is only expressed upon proliferative 
action [9]. ALDH1 was almost equally present in pectoralis and psoas 
muscle, and a trend of higher expression of isoform ALDH1A3 in comparison 
to ALDH1A1 could be detected. It is most likely that the low frequency of 
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ALDH1 positive non-SCs represent CD68 positive macrophages, which are 
known to be positive for ALDH1 [10]. 
Our data corroborate prior results from experimental studies and show that 
ALDH1A1 and ALDH1A3 are expressed in human skeletal muscle SCs 
where they could be involved in differentiation and regenerative functions. 
The identification of ALDH1 isoforms in SC biology is of particular interest 
since the functional processes regulating SC activation including asymmetric 
division and senescence are still poorly understood. Interference with ALDH 
enzymatic activity could then open novel approaches for the treatment of 
muscular diseases (Figures 1 and 2) (Table 1).
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Figure 1: Immunostaining of CD56, Pax7, ALDH1 and isoforms ALDH1A1, 
ALDH1A3, respectively, in human skeletal muscle.
A, B: CD56 positive SC in cross (A) and longitudinal orientated (B) sections 
of psoas muscle | C, D: Pax7 positive SC in psoas (C) and pectoralis muscle 
(D)| E, F: ALDH1 positive cells in psoas (E) and pectoralis muscle (F) | G: 
ALDH1A1 positive cells in pectoralis muscle.
Figure 2: Co-immunofluorescent staining of CD56-ALDH1, Pax7-ALDH1A1 
and Pax7-ALDH1A3 in longitudinal orientated human skeletal muscle.
A, B: Merge of CD56-ALDH1 coexpression in SC diaphragm (A) and psoas 
muscle (B) | A1, A2: Single captures of ALDH1 (A1) and CD56 (A2) positive 
cells | B1, B2: Single captures of ALDH1 (B1) and CD56 (B2) | C: Merge 
of Pax7-ALDH1A1 co-expression in SC in pectoralis muscle | C1, C2: Single 
captures of ALDH1A1 (C1) and Pax7 (C2) positive cells| D: Merge of Pax7-
ALDH1A3 co-expression in SC pectoralis muscle | D1, D2: Single captures of 
ALDH1A3 (D1) and Pax7 (D2) positive cells.
A CD56 positive cells Pax7 positive cells
Tissue Mean value per 
50 fibres
Mean value per 50 fibers
M. pectoralis 22.5 12
Diaphragm 22 11.5
M. psoas 13.8 9
Total 19.4 10.8




M. pectoralis 21.7 12 12.5
Diaphragm 50 6.5 11.5
M. psoas 22.7 4.5 6.5
Total 31.5 7.6 10.2
Table 1 Quantitative analysis of immunohistochemistry: Mean value of 
immunoreactive cells of anti-CD56 and anti-Pax7 (A) as well as anti-ALDH1, 
anti-ALDH1A1, anti-ALDH1A3 (B) antibody staining counted in 50 fibres per 
sample.
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